skip to Main Content

Genetic Testing Essential to Advancing Pancreatic Cancer Paradigm

Newsfeed image, light gray text on dark gray background
Although pancreatic cancer has not seen the rapid emergence of new agents occurring in other oncology fields, more widespread utilization of genetic testing may offer investigators a leg up in the fight against the disease, said Margaret A. Tempero, MD.


Arguably the biggest advancement made in recent years has been with the introduction of FOLFIRINOX in the adjuvant setting. Read more . . .


Back To Top